Showing results (31-40 of 264) with videos related to
Sort By:
Pageof 27
Immunity|April 24, 2012
Janus kinase deregulation in leukemia and lymphomaEdwin Chen, Louis M Staudt, Anthony R GreenProceedings of the National Academy of Sciences of the United States of America|March 20, 2016
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2Daniel J Hodson, Arthur L Shaffer, Wenming Xiao, et al.Nature|June 24, 2008
IRF4 addiction in multiple myelomaArthur L Shaffer, N C Tolga Emre, Laurence Lamy, et al.Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
High-throughput RNA sequencing in B-cell lymphomasWenming Xiao, Bao Tran, Louis M Staudt, et al.Oncotarget|November 16, 2017
PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphomaGeorgios N Pongas, Christina M Annunziata, Louis M StaudtNature Immunology|September 22, 2011
Malignant pirates of the immune systemLixin Rui, Roland Schmitz, Michele Ceribelli, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Dendritic cell fate is determined by BCL11AGregory C Ippolito, Joseph D Dekker, Yui-Hsi Wang, et al.Molecular Cancer|May 18, 2006
Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cellsHui Liu, Gregory C Ippolito, Jason K Wall, et al.Blood|September 25, 2015
ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humansKaren S Hathcock, Hesed M Padilla-Nash, Jordi Camps, et al.Blood|June 22, 2012
Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4Xiangao Huang, Maurizio Di Liberto, David Jayabalan, et al.Pageof 27